Henry Schein (NASDAQ:HSIC) Earns Neutral Rating from Analysts at Mizuho

Mizuho started coverage on shares of Henry Schein (NASDAQ:HSIC) in a research report report published on Wednesday, MarketBeat.com reports. The brokerage issued a neutral rating and a $75.00 target price on the stock.

Other analysts have also recently issued reports about the stock. JPMorgan Chase & Co. lowered their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Evercore ISI boosted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Robert W. Baird lowered their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Barrington Research reissued an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. Seven analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $78.89.

Henry Schein Stock Down 1.0 %

HSIC stock opened at $74.49 on Wednesday. The stock has a market capitalization of $9.29 billion, a P/E ratio of 30.65, a PEG ratio of 2.20 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a one year low of $63.67 and a one year high of $82.63. The company has a 50 day moving average price of $71.76 and a two-hundred day moving average price of $69.92.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the previous year, the company earned $1.32 EPS. As a group, sell-side analysts expect that Henry Schein will post 4.78 EPS for the current year.

Insiders Place Their Bets

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. The trade was a 12.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This represents a 22.65 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Henry Schein

Institutional investors have recently modified their holdings of the stock. Cromwell Holdings LLC raised its stake in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares in the last quarter. Summit Securities Group LLC acquired a new stake in shares of Henry Schein in the 2nd quarter valued at about $31,000. Blue Trust Inc. raised its stake in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after purchasing an additional 475 shares in the last quarter. Farther Finance Advisors LLC raised its stake in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares in the last quarter. Finally, Mather Group LLC. raised its stake in shares of Henry Schein by 16.8% in the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after purchasing an additional 216 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.